A
Anbio Biotechnology
NASDAQ:NNNN
Anbio Biotechnology
NASDAQ:NNNN
Price:
25.85
USD
0.54%
Market Closed
Market Cap:
$3.7B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
A
|
Anbio Biotechnology
NASDAQ:NNNN
|
DE |
|
Symbolic Logic Inc
OTC:EVOL
|
US |
|
O
|
OliPass Corp
KOSDAQ:244460
|
KR |
|
C
|
Cummins Inc
LSE:0I58
|
US |
|
JD Health International Inc
HKEX:6618
|
CN |
|
Modern Cinema Group Inc
OTC:MOCI
|
CH |
|
G
|
Gamedust SA
WSE:GDC
|
PL |
Anbio Biotechnology
Anbio Biotechnology is a DE-based company operating in Biotechnology industry. The company is headquartered in Frankfurt, Hessen. The company went IPO on 2025-02-19. Anbio Biotechnology is a Germany-based company. The firm is primarily engaged in the manufacturing of In Vitro Diagnostic Substance.
Anbio Biotechnology
Business Overview
Anbio Biotechnology is a DE-based company operating in Biotechnology industry. The company is headquartered in Frankfurt, Hessen. The company went IPO on 2025-02-19. Anbio Biotechnology is a Germany-based company. The firm is primarily engaged in the manufacturing of In Vitro Diagnostic Substance.
No Earnings Calls Available
Management
Mr. Michael Lau M.B.A., Ph.D.
Chief Executive Officer
No Bio Available
Ms. Suki Song CPA
Chief Financial Officer
No Bio Available
Mr. Chris Tian
Chief Business Officer
No Bio Available
Contacts
Address
HESSEN
Frankfurt
Wilhelm Gutbrod Str 21b
Contacts
+4916096247281
